ISSN:
1432-2072
Keywords:
Clorazepate
;
Desmethyldiazepam
;
Benzodiazepines
;
Pharmacokinetics
;
Geriatrics
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Abstract Desmethyldiazepam (DMDZ) disposition was evaluated in 32 healthy male and female volunteers who ingested single 15-mg doses of the precursor compound, clorazepate dipotassium. DMDZ concentrations were measured in multiple plasma samples obtained between 7 and 9 days after dosage. Appearance of DMDZ in blood was rapid, with peak concentrations attained on average 1.5 h after dosage. Absorption half-life (t 1/2 a) averaged 24 min. Neither peak time nor t 1/2 a were influenced by age or sex. After a rapid phase of distribution, DMDZ elimination was slow, with a mean elimination half-life (t 1/2 β) of 82 h (range 27–219 h). t 1/2 β became prolonged with age in men but not in women Likewise, clearance of total (free plus bound) DMDZ declined with age in male subjects (r=−0.47, P〈0.1), but was unrelated to age in women. DMDZ was extensively bound to protein in all subjects. The mean free fraction (FF) was 3.1% (range 2.0–4.3%), and increased significantly with declining plasma albumin concentrations (r=−0.57, P〈0.001). Partly due to a decline in plasma albumin with age (r=−0.47, P〈0.01), FF tended to increase with age (r=0.23). After correction for individual differences in FF, clearance of pharmacologically active unbound DMDZ declined significantly with age in men (r=−0.62, P〈0.01), but actually was slightly higher, in elderly as opposed to young women. Thus, the age-related decline in the capacity for hepatic hydroxylation of DMDZ is highly sex-specific.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/BF00432186
Permalink
